跳至主要内容
临床试验/EUCTR2017-003683-12-ES
EUCTR2017-003683-12-ES进行中(未招募)1 期

Sentinel node in ovarian cáncer: tailoring clinical feasibility

INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE0 个研究点目标入组 20 人开始时间: 2017年12月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • · Informed consent signed prior to performing any procedure related to the clinical trial.
  • · Women over 18 years old at the time of inclusion.
  • · Patients with anatomopathological diagnosis of malignant ovarian tumor in a deferred study, proposals for staging surgery or patients with suspicious of malignant tumor who are going to be subjected to exploratory laparotomy and operative biopsy, and in case of positivity, staging surgery will be performed.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • · Non-obtaining / informed consent withdrawal.
  • · Benign result in extemporaneous study.
  • · Previous history of vascular surgery in the aorta, cava or pelvic vessels.
  • · Previous pelvic or paraaortic lymphadenectomy.
  • · Previous lymphoma.
  • · Previous abdominopelvic tumor.
  • · Previous allergic reaction to indocyanine green.
  • · Pregnancy / Breastfeeding.

研究者

发起方
INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE

相似试验

Feasibility of performing the Sentinel Node... | 临床试验